|

Control Clinical Trials

6 actively recruiting trials across 1 location

No change since May 2026

Pipeline

Phase 2: 2Phase 3: 4

Top Sponsors

  • Umeå University1
  • Suzhou Immunofoco Biotechnology Co., Ltd1
  • Gruppo Oncologico del Nord-Ovest1
  • First Affiliated Hospital of Zhejiang University1
  • Beth Israel Deaconess Medical Center1

Indications

Other5 trials

A Phase III Randomized Study in CLDN18.2-positive Unresectable Locally Advanced Gastric Cancer Patients
Phase 3
Adjuvant TRastuzumab Deruxtecan for HER2-positive Gastroesophageal Cancer With Persistence of miNImal Residual Disease
Phase 2
BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases
Phase 3
Probiotic Supplements in Osteoarthritis
Phase 3
SCRT Combined With Chemotherapy and Iparomlimab and Tuvonralimab in MSS or pMMR Patients With Locally Advanced Rectal Cancer
Phase 2

Boston, Massachusetts1 trial

The SCOPE Trial: Sleep, Cognition, and Pain Bundle vs. ERAS-cardiac for Postoperative Delirium

Massachusetts General Hospital

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.